Stigmasterol attenuates hepatic steatosis in rats by strengthening the intestinal barrier and improving bile acid metabolism
Abstract Stigmasterol (ST) has been shown to improve both lipid and bile acid (BA) metabolism. However, the mechanism(s) by which ST prevents dyslipidemia via BA metabolism, and the potential involvement of other regulatory mechanisms, remains unclear. Here, we found that ST treatment effectively al...
Main Authors: | Yaxin Zhang, Yuyan Gu, Jing Jiang, Xiaobing Cui, Saibo Cheng, Linling Liu, Zhiyong Huang, Rongxin Liao, Peng Zhao, Jieying Yu, Jing Wang, Yuhua Jia, Wen Jin, Fenghua Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-08-01
|
Series: | npj Science of Food |
Online Access: | https://doi.org/10.1038/s41538-022-00156-0 |
Similar Items
-
Health Benefits and Pharmacological Properties of Stigmasterol
by: Saad Bakrim, et al.
Published: (2022-09-01) -
Bile Acids, Intestinal Barrier Dysfunction, and Related Diseases
by: Linsen Shi, et al.
Published: (2023-07-01) -
Liver Steatosis and Steatohepatitis Alter Bile Acid Receptors in Brain and Induce Neuroinflammation: A Contribution of Circulating Bile Acids and Blood-Brain Barrier
by: Noemi Fiaschini, et al.
Published: (2022-11-01) -
<i>Lactobacillus johnsonii</i> Attenuates Liver Steatosis and Bile Acid Dysregulation in Parenteral Nutrition-Fed Rats
by: Juan Xu, et al.
Published: (2023-09-01) -
Why Do Plants Convert Sitosterol to Stigmasterol?
by: Siddique I. Aboobucker, et al.
Published: (2019-03-01)